APA

Aourz N., Serruys A. K., Chabwine J. N., Balegamire P. B., Afrikanova T., Edrada-Ebel R., Grey A. I., Kamuhabwa A. R., Walrave L., Esguerra C. V., van Leuven F., de Witte P. A. M., Smolders I. & Crawford A. D. (20200424). Identification of GSK-3 as a Potential Therapeutic Entry Point for Epilepsy. : ACS chemical neuroscience.

Chicago

Aourz Najat, Serruys Ann-Sophie K, Chabwine Joëlle N, Balegamire Pascal Byenda, Afrikanova Tatiana, Edrada-Ebel RuAngelie, Grey Alexander I, Kamuhabwa Appolinary R, Walrave Laura, Esguerra Camila V, van Leuven Fred, de Witte Peter A M, Smolders Ilse and Crawford Alexander D. 20200424. Identification of GSK-3 as a Potential Therapeutic Entry Point for Epilepsy. : ACS chemical neuroscience.

Harvard

Aourz N., Serruys A. K., Chabwine J. N., Balegamire P. B., Afrikanova T., Edrada-Ebel R., Grey A. I., Kamuhabwa A. R., Walrave L., Esguerra C. V., van Leuven F., de Witte P. A. M., Smolders I. and Crawford A. D. (20200424). Identification of GSK-3 as a Potential Therapeutic Entry Point for Epilepsy. : ACS chemical neuroscience.

MLA

Aourz Najat, Serruys Ann-Sophie K, Chabwine Joëlle N, Balegamire Pascal Byenda, Afrikanova Tatiana, Edrada-Ebel RuAngelie, Grey Alexander I, Kamuhabwa Appolinary R, Walrave Laura, Esguerra Camila V, van Leuven Fred, de Witte Peter A M, Smolders Ilse and Crawford Alexander D. Identification of GSK-3 as a Potential Therapeutic Entry Point for Epilepsy. : ACS chemical neuroscience. 20200424.